Teva Wants 'Scattershot' 401(k) Fee Suit Scrapped
Teva Pharmaceuticals USA Inc. has urged a Pennsylvania federal judge to toss a "scattershot" proposed class action accusing the drugmaker of saddling participants in its 401(k) plan with excessive fees, arguing...To view the full article, register now.
Already a subscriber? Click here to view full article